Rossari Biotech is trading -0.25% lower at Rs 685.80 as compared to its last closing price. Rossari Biotech has been trading in the price range of 688.60 & 677.00. Rossari Biotech has given -12.38% in this year & 6.80% in the last 5 days. Rossari Biotech has TTM P/E ratio 31.57 as compared to the sector P/E of 17.95.There are 5 analysts who have initiated coverage on Rossari Biotech. There are 4 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 31.70 Crores in its last quarter.Listed peers of Rossari Biotech include Grauer & Weil (india) (1.79%), Nacl Industries (5.00%), Rossari Biotech (-0.25%).The Mutual Fund holding in Rossari Biotech was at 13.25% in 31 Dec 2024. The MF holding has increased from the last quarter. The FII holding in Rossari Biotech was at 3.74% in 31 Dec 2024. The FII holding has decreased from the last quarter.
Updated on Apr 19, 2025, 02:01 PM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Grauer & Weil (india) | Moderately Bearish | 85.82 | 1.79 | 3,891.18 | 26.62 | 4.83 | 0.58 | 0.68 |
Nacl Industries | Bullish | 190.20 | 5.00 | 3,793.33 | - | 7.39 | - | 29.23 |
Rossari Biotech | Neutral | 685.80 | -0.25 | 3,796.85 | 29.14 | 3.59 | 0.07 | 4.22 |
Bhagiradha Chemicals & Industri | Moderately Bearish | 284.55 | -0.94 | 3,689.73 | 177.22 | 7.16 | 0.04 | 4.15 |
Kiri Industries | Bullish | 641.80 | -0.13 | 3,570.27 | 25.01 | 1.18 | - | 0.85 |
Meeting Date | Purpose |
---|---|
2025-01-21 | Quarterly Results |
2024-10-19 | Quarterly Results |
2024-07-20 | Quarterly Results |
2024-04-29 | Audited Results & Final Dividend |
2024-01-20 | Quarterly Results |
Rossari Biotech is trading at 685.80 as on Thu Apr 17 2025 09:59:43. This is -0.25% lower as compared to its previous closing price of 687.55.
The market capitalization of Rossari Biotech is 3796.85 Cr as on Thu Apr 17 2025 09:59:43.
The average broker rating on Rossari Biotech is Strong Buy. The breakup of analyst rating is given below -
The 52 wk high for Rossari Biotech is 966.00 whereas the 52 wk low is 568.05
Rossari Biotech can be analyzed on the following key metrics -
Rossari Biotech reported a net profit of 130.69 Cr in 2024.
The Mutual Fund Shareholding was 13.25% at the end of 31 Dec 2024.